Top

Published in:

01-01-2014 | AUTOIMMUNITY (TK TARRANT, SECTION EDITOR)

Autoimmunity in the Pathogenesis and Treatment of Keratoconjunctivitis Sicca

Authors: Katy C. Liu, Kyle Huynh, Joseph Grubbs Jr., Richard M. Davis

Published in: Current Allergy and Asthma Reports | Issue 1/2014

Abstract

Dry eye is a chronic corneal disease that impacts the quality of life of many older adults. Keratoconjunctivitis sicca (KCS), a form of aqueous-deficient dry eye, is frequently associated with Sjögren’s syndrome and mechanisms of autoimmunity. For KCS and other forms of dry eye, current treatments are limited, with many medications providing only symptomatic relief rather than targeting the pathophysiology of disease. Here, we review proposed mechanisms in the pathogenesis of autoimmune-based KCS: genetic susceptibility and disruptions in antigen recognition, immune response, and immune regulation. By understanding the mechanisms of immune dysfunction through basic science and translational research, potential drug targets can be identified. Finally, we discuss current dry eye therapies as well as promising new treatment options and drug therapy targets.

Schein OD, Hochberg MC, Munoz B, Tielsch JM, Bandeen-Roche K, Provost T, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999;159(12):1359–63.PubMedCrossRef

Report of the definition and classification subcommittee of the international dry eye workshop the definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The Ocular Surface. 2007;5(2):75–92.

Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003;48(8):2240–5.PubMedCrossRef

Chen KS, Jiang MC, Li CJ, Liu OK, Tsai CS. Discrimination between Sjogren's and non-Sjogren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens. J Intern Med Res. 2009;37(4):1088–96.CrossRef

Mimori T. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. Intern Med. 1999;38(7):523–32.PubMedCrossRef

Muller S, Briand JP, Barakat S, Lagueux J, Poirier GG, De Murcia G, et al. Autoantibodies reacting with poly(ADP-ribose) and with a zinc-finger functional domain of poly(ADP-ribose) polymerase involved in the recognition of damaged DNA. Clin Immunol Immunopathol. 1994;73(2):187–96.PubMedCrossRef

Haaheim LR, Halse AK, Kvakestad R, Stern B, Normann O, Jonsson R. Serum antibodies from patients with primary Sjogren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. Scand J Immunol. 1996;43(1):115–21.PubMedCrossRef

Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol. 2005;141(1):148–54.PubMedCentralPubMedCrossRef

Manganelli P, Fietta P. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum. 2003;33(1):49–65.PubMedCrossRef

10.

Franz S, Gaipl US, Munoz LE, Sheriff A, Beer A, Kalden JR, et al. Apoptosis and autoimmunity: when apoptotic cells break their silence. Curr Rheumatol Rep. 2006;8(4):245–7.PubMedCrossRef

11.

Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjogren's syndrome. Clin Exp Rheumatol. 1998;16(5):561–8.PubMed

12.

Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death and repair in Sjogren's syndrome (SS). Clin Exp Immunol. 1998;114(3):485–90.PubMedCentralPubMedCrossRef

13.

Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Investig Ophthalmol Vis Sci. 2003;44(1):124–9.CrossRef

14.

Rosen A, Casciola-Rosen L. Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med Off Publ Am Assoc Oral Biol. 2004;15(3):156–64.CrossRef

15.

Theofilopoulos AN, Kono DH, Beutler B, Baccala R. Intracellular nucleic acid sensors and autoimmunity. J Interf Cytokine Res Off J Intern Soc Interf Cytokine Res. 2011;31(12):867–86.CrossRef

16.

Yamazaki S, Muta T, Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J Biol Chem. 2001;276(29):27657–62.PubMedCrossRef

17.•

Okuma A, Hoshino K, Ohba T, Fukushi S, Aiba S, Akira S, et al. Enhanced apoptosis by disruption of the STAT3-IkappaB-zeta signaling pathway in epithelial cells induces Sjogren's syndrome-like autoimmune disease. Immunity. 2013;38(3):450–60. This recent study finds Sjögren’s-like disease develops with disruption of the STAT3-IκB apoptotic pathway.PubMedCrossRef

18.

Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282(13):9358–63.PubMedCrossRef

19.

Zhang X, Chen W, De Paiva CS, Corrales RM, Volpe EA, McClellan AJ, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Investig Ophthalmol Vis Sci. 2011;52(9):6279–85.CrossRef

20.

Brignole F, Pisella PJ, Goldschild M, De Saint JM, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Investig Ophthalmol Vis Sci. 2000;41(6):1356–63.

21.

Stern ME, Schaumburg CS, Siemasko KF, Gao J, Wheeler LA, Grupe DA, et al. Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Investig Ophthalmol Vis Sci. 2012;53(4):2062–75.CrossRef

22.

Liu X, Wang S, Kao AA, Long Q. The effect of topical pranoprofen 0.1 % on the clinical evaluation and conjunctival HLA-DR expression in dry eyes. Cornea. 2012;31(11):1235–9.PubMedCrossRef

23.

Baudouin C, Brignole F, Pisella PJ, De Jean MS, Goguel A. Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A. Adv Exp Med Biol. 2002;506(Pt B):761–9.PubMedCrossRef

24.

Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Investig Ophthalmol Vis Sci. 2003;44(2):581–9.CrossRef

25.

Pisella PJ, Brignole F, Debbasch C, Lozato PA, Creuzot-Garcher C, Bara J, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology. 2000;107(10):1841–9.PubMedCrossRef

26.

Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31(3):271–85.PubMedCentralPubMedCrossRef

27.

Lin H, Li W, Dong N, Chen W, Liu J, Chen L, et al. Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. Investig Ophthalmol Vis Sci. 2010;51(1):122–8.CrossRef

28.

Moutsopoulos HM, Hooks JJ, Chan CC, Dalavanga YA, Skopouli FN, Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis. 1986;45(8):677–83.PubMedCrossRef

29.

Hamrah P, Liu Y, Zhang Q, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol. 2003;121(8):1132–40.PubMedCrossRef

30.

Paul P, van den Hoorn T, Jongsma ML, Bakker MJ, Hengeveld R, Janssen L, et al. A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell. 2011;145(2):268–83.PubMedCrossRef

31.

Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 1996;15(6):605–14.PubMedCrossRef

32.

Zheng X, De Paiva CS, Rao K, Li DQ, Farley WJ, Stern M, et al. Evaluation of the transforming growth factor-beta activity in normal and dry eye human tears by CCL-185 cell bioassay. Cornea. 2010;29(9):1048–54.PubMedCentralPubMedCrossRef

33.

Shen L, Barabino S, Taylor AW, Dana MR. Effect of the ocular microenvironment in regulating corneal dendritic cell maturation. Arch Ophthalmol. 2007;125(7):908–15.PubMedCrossRef

34.

De Paiva CS, Volpe EA, Gandhi NB, Zhang X, Zheng X, Pitcher 3rd JD, et al. Disruption of TGF-beta signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PloS One. 2011;6(12):e29017.PubMedCentralPubMedCrossRef

35.

Turpie B, Yoshimura T, Gulati A, Rios JD, Dartt DA, Masli S. Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am J Pathol. 2009;175(3):1136–47.PubMedCrossRef

36.

Li H, Dai M, Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity. 2004;21(4):551–60.PubMedCrossRef

37.

Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J, et al. Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176(7):3950–7.PubMed

38.

Salinas GF, Braza F, Brouard S, Tak PP, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol. 2013;146(1):34–45.PubMedCrossRef

39.

Cornec D, Devauchelle-Pensec V, Tobon GJ, Pers JO, Jousse-Joulin S, Saraux A. B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39(3):161–7.PubMedCrossRef

40.

Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, et al. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc Natl Acad Sci U S A. 1998;95(13):7538–43.PubMedCentralPubMedCrossRef

41.

Voulgarelis M, Moutsopoulos HM. Lymphoproliferation in autoimmunity and Sjogren's syndrome. Curr Rheumatol Rep. 2003;5(4):317–23.PubMedCrossRef

42.

Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 2003;48(11):3187–201.PubMedCrossRef

43.

Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 2005;52(5):1534–44.PubMedCrossRef

44.

Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Investig. 2002;109(1):59–68.PubMed

45.

Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2(7):465–75.PubMedCrossRef

46.

De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher III JD, Fang B, Zheng X, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal immunol. 2009;2(3):243–53.PubMedCentralPubMedCrossRef

47.

Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum. 2000;43(12):2807–17.PubMedCrossRef

48.

Goicovich E, Molina C, Perez P, Aguilera S, Fernandez J, Olea N, et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 2003;48(9):2573–84.PubMedCrossRef

49.

Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI, et al. Analysis of Tear Cytokines and Clinical Correlations in Sjogren Syndrome Dry Eye Patients and Non-Sjogren Syndrome Dry Eye Patients. Am J Ophthalmol. 2013;156:247–253.

50.

Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB. Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther. 2010;12(6):R220.PubMedCentralPubMedCrossRef

51.

Holtta V, Klemetti P, Sipponen T, Westerholm-Ormio M, Kociubinski G, Salo H, et al. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis. 2008;14(9):1175–84.PubMedCrossRef

52.

Williams RO, Paleolog E, Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol. 2007;7(4):412–7.PubMedCrossRef

53.

Bernard F, Romano A, Granel B (2010) [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjogren's syndrome]. La Revue de medecine interne / fondee par la Societe nationale francaise de medecine interne.(2):116–27. Lymphocytes T regulateurs et maladies auto-immunes systemiques : lupus erythemateux systemique, polyarthrite rhumatoide et syndrome de Gougerot-Sjogren primaire.

54.

Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009;182(3):1247–52.PubMedCentralPubMed

55.

Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol. 2009;175(3):1167–77.PubMedCrossRef

56.

Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology. 1999;106(4):811–6.PubMedCrossRef

57.

Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136(4):593–602.PubMedCrossRef

58.

Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009;54(3):321–38.PubMedCrossRef

59.

Tsubota K, Fujita H, Tadano K, Takeuchi T, Murakami T, Saito I, et al. Improvement of lacrimal function by topical application of CyA in murine models of Sjogren's syndrome. Investig Ophthalmol Vis Sci. 2001;42(1):101–10.

60.

Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107(4):631–9.PubMedCrossRef

61.

Samarkos M, Moutsopoulos HM. Recent advances in the management of ocular complications of Sjogren's syndrome. Curr Allergy Asthma Rep. 2005;5(4):327–32.PubMedCrossRef

62.

Gao J, Sana R, Calder V, Calonge M, Lee W, Wheeler LA, et al. Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin a. Investig Ophthalmol Vis Sci. 2013;54(7):4717–33.CrossRef

63.

Fleck M, Zhang HG, Kern ER, Hsu HC, Muller-Ladner U, Mountz JD. Treatment of chronic sialadenitis in a murine model of Sjogren's syndrome by local fasL gene transfer. Arthritis Rheum. 2001;44(4):964–73.PubMedCrossRef

64.

Nakamura S, Shibuya M, Saito Y, Nakashima H, Saito F, Higuchi A, et al. Protective effect of D-beta-hydroxybutyrate on corneal epithelia in dry eye conditions through suppression of apoptosis. Investig Ophthalmol Vis Sci. 2003;44(11):4682–8.CrossRef

65.

Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, et al. Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol. 2004;138(1):6–17.PubMedCrossRef

66.

Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, et al. Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med. 2002;162(11):1293–300.PubMedCrossRef

67.

Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46(3):748–54.PubMedCrossRef

68.

Abdulahad WH, Kroese FG, Vissink A, Bootsma H. Immune regulation and B-cell depletion therapy in patients with primary Sjogren's syndrome. J Autoimmun. 2012;39(1–2):103–11.PubMedCrossRef

69.•

Rocha EM, Di Pasquale G, Riveros PP, Quinn K, Handelman B, Chiorini JA. Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland. Investig Ophthalmol Vis Sci. 2011;52(13):9567–72. This study establishes that adenoviral-associated vectors can be delivered to murine lacrimal glands, supporting gene therapy as a potential treatment method for KCS.CrossRef

70.

Rocha EM, Cotrim AP, Zheng C, Riveros PP, Baum BJ, Chiorini JA. Recovery of radiation-induced dry eye and corneal damage by pretreatment with adenoviral vector-mediated transfer of erythropoietin to the salivary glands in mice. Hum Gene Ther. 2013;24(4):417–23.PubMedCrossRef

71.

Contreras-Ruiz L, Zorzi GK, Hileeto D, Lopez-Garcia A, Calonge M, Seijo B, et al. A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model. Gene Ther. 2013;20(5):467–77.PubMedCrossRef

Title: Autoimmunity in the Pathogenesis and Treatment of Keratoconjunctivitis Sicca
Authors: Katy C. Liu
Kyle Huynh
Joseph Grubbs Jr.
Richard M. Davis
Publication date: 01-01-2014
Publisher: Springer US
Published in: Current Allergy and Asthma Reports / Issue 1/2014
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI: https://doi.org/10.1007/s11882-013-0403-7

At a glance: The STEP trials

Springer Medicine

Autoimmunity in the Pathogenesis and Treatment of Keratoconjunctivitis Sicca

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Role of “Western Diet” in Inflammatory Autoimmune Diseases

Complexities in the Relationship Between Infection and Autoimmunity

Utility of Immunologic Testing in Suspected Rheumatologic Disease

Noninfectious Immune-Mediated Uveitis and Ocular Inflammation

Emerging Role of Human Basophil Biology in Health and Disease

Irritant-Induced Asthma in the Workplace